Manchon, Enzo
Hirt, Nell
Versier, Benjamin
Soundiramourty, Aravindhan
Juricek, Ludmila
Lebbe, Celeste
Battistella, Maxime
Christen, Yves
Mallet, Jacques
Charron, Dominique
Jabrane-Ferrat, Nabila https://orcid.org/0000-0003-4809-7836
Serguera, Che
Al-Daccak, Reem
Funding for this research was provided by:
Fondation de l'Avenir pour la Recherche Médicale Appliquée (AP-RM-22-006)
Agence Nationale de la Recherche (MetaboHUB-ANR-11-INBS-0010)
Asfalia biologics
Article History
Received: 9 January 2025
Accepted: 18 April 2025
First Online: 8 May 2025
Competing interests
: Benjamin Versier, Aravindhan Soundiramourty, Yves Christen, Dominique Charron, Jacques Mallet, and Che Serguera serve Asfalia Biologics. Ludmila Juricek previously served at Asfalia Biologics and currently serves for Coave Therapeutics. The authors declare that a patent application related to this work has been filed. The other authors declare that they have no conflicts of interest.